NLRP3 and neoplasm: Dying tumor cells treated with chemotherapy release ATP, which activates the NLRP3 inflammasome and IL-1β–IL-1 receptor (IL-1R) signaling in dendritic cells, driving an effective CD8 T-cell response against transplantable tumor cells (113).